Myorelaxation Practice in Paediatric Anesthesia

NCT03086915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1650

Last updated 2018-11-19

No results posted yet for this study

Summary

In retrospective data search the investigators will identified the percentage of patients with muscle relaxants administered during perioperative period. The block reversal, typ of drug, percentage of cases with and without reversal will be identified.

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

Neuromuscular Blocking Agent

Administration of neuromuscular blockers during anesthesia

Sponsors & Collaborators

  • Masaryk University

    collaborator OTHER
  • Brno University Hospital

    lead OTHER

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-05
Primary Completion
2017-07-30
Completion
2017-08-01

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03086915 on ClinicalTrials.gov